Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
iShares Biotechnology ETF
IBB
$10.7B
| $82.4M | 0.16% |
814,485
+370,863
| +84% | +$44.5M |
|
127
Essex Property Trust
ESS
$18.6B
| $80.9M | 0.16% |
362,075
+7,986
| +2% | +$1.76M |
|
|
MXIM
128
DELISTED
Maxim Integrated Products
MXIM
| $80.6M | 0.16% |
2,412,405
+2,345,722
| +3,518% | +$77.7M |
|
129
Equity Lifestyle Properties
ELS
$12.7B
| $80.5M | 0.16% |
2,749,870
+300,634
| +12% | +$8.55M |
|
130
Broadcom
AVGO
$1.75T
| $80.3M | 0.16% |
6,425,420
-926,470
| -13% | -$11.7M |
|
131
Westlake Corp
WLK
$10.1B
| $80.1M | 0.16% |
1,543,609
+1,140,468
| +283% | +$66.6M |
|
132
Trip.com Group
TCOM
$29B
| $79.5M | 0.15% |
2,516,724
-1,160,284
| -32% | -$40.3M |
|
133
Zions Bancorporation
ZION
$9.95B
| $79.4M | 0.15% |
2,884,311
-441,269
| -13% | -$13.1M |
|
134
Abbott
ABT
$202B
| $78.1M | 0.15% |
1,940,600
+435,720
| +29% | +$20.5M |
|
135
Gilead Sciences
GILD
$181B
| $77.8M | 0.15% |
792,250
+114,967
| +17% | +$12.8M |
|
136
Wells Fargo
WFC
$254B
| $77.6M | 0.15% |
1,511,098
+433,282
| +40% | +$23.8M |
|
|
CONE
137
DELISTED
CyrusOne Inc Common Stock
CONE
| $77.1M | 0.15% |
2,359,548
-34,657
| -1% | -$1.1M |
|
138
BioMarin Pharmaceuticals
BMRN
$12.9B
| $77M | 0.15% |
731,424
-304,218
| -29% | -$40.6M |
|
|
AET
139
DELISTED
Aetna Inc
AET
| $76.2M | 0.15% |
696,604
+4,749
| +0.7% | +$549K |
|
|
HOT
140
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $76.2M | 0.15% |
1,145,476
-700,668
| -38% | -$53.3M |
|
|
IOC
141
DELISTED
Interoil Corporation
IOC
| $75.9M | 0.15% |
2,251,927
+1,266,424
| +129% | +$51.2M |
|
142
NNN REIT
NNN
$8.8B
| $75.4M | 0.15% |
2,078,216
+832,032
| +67% | +$30.2M |
|
143
Camden Property Trust
CPT
$10.8B
| $75.3M | 0.15% |
+1,019,232
| New | +$77.3M |
|
144
Sherwin-Williams
SHW
$84.1B
| $75.1M | 0.15% |
1,011,468
+726,363
| +255% | +$63.7M |
|
145
Western Digital
WDC
$166B
| $74.6M | 0.14% |
1,243,154
+448,421
| +56% | +$27M |
|
|
TCF
146
DELISTED
TCF Financial Corporation
TCF
| $74.1M | 0.14% |
4,889,760
+2,083,979
| +74% | +$33.1M |
|
|
ETFC
147
DELISTED
E*Trade Financial Corporation
ETFC
| $74.1M | 0.14% |
2,813,250
+2,237,175
| +388% | +$62M |
|
|
APC
148
DELISTED
Anadarko Petroleum
APC
| $74.1M | 0.14% |
1,226,434
+43,329
| +4% | +$3.08M |
|
149
J.M. Smucker
SJM
$13.3B
| $73.3M | 0.14% |
642,441
+619,844
| +2,743% | +$69.1M |
|
|
RICE
150
DELISTED
Rice Energy Inc.
RICE
| $72M | 0.14% |
4,455,098
-1,545,389
| -26% | -$29.5M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.